[1] World Health Organization. WHO framework convention on tobacco control. https://www.who.int/nmh/publications/fact_sheet_tobacco_en.pdf. [2020-05-21].https://www.who.int/nmh/publications/fact_sheet_tobacco_en.pdf
[2] GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1923 − 94. http://dx.doi.org/10.1016/S0140-6736(18)32225-6CrossRef
[3] U.S. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): People who are at higher risk for severe illness. https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/people-at-higher-risk.html. [2020-05-21].https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/people-at-higher-risk.html
[4] Wu J. An important but overlooked measure for containing the COVID-19 epidemic: protecting patients with chronic diseases. China CDC Weekly 2020;2(15):249 − 50. http://dx.doi.org/10.46234/ccdcw2020.064CrossRef
[5] U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress. A report of the surgeon general supplemental evidence tables. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2014. https://bookstore.gpo.gov/products/health-consequences-smoking-50-years-progress-report-surgeon-general-supplemental-evidence
[6] World Health Organization. Q & A: smoking and COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-on-smoking-and-covid-19#. [2020-05-21].https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-on-smoking-and-covid-19#
[7] Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Eng J Med 2020. http://dx.doi.org/10.46234/ccdcw2020.064CrossRef
[8] Patanavanich R, Glantz S. Smoking is associated with COVID-19 progression: A meta-analysis. Nicotine & Tobacco Research. http://dx.doi.org/10.1093/ntr/ntaa082.http://dx.doi.org/10.1093/ntr/ntaa082
[9] News Medical. NICE guidelines strongly encourage COPD patients to quit smoking for COVID-19. https://www.news-medical.net/news/20200416/NICE-guidelines-strongly-encourage-COPD-patients-to-quit-smoking-for-COVID-19.aspx. [2020-05-21].https://www.news-medical.net/news/20200416/NICE-guidelines-strongly-encourage-COPD-patients-to-quit-smoking-for-COVID-19.aspx
[10] Canadian Lung Association. COVID-19: FAQs. https://www.lung.ca/news/latest-news/covid-19-faqs. [2020-05-21].https://www.lung.ca/news/latest-news/covid-19-faqs
[11] Eisenberg SL, Eisenberg MJ. Smoking cessation during the COVID-19 epidemic. Nicotine & Tobacco Research. http://dx.doi.org/10.1093/ntr/ntaa075.http://dx.doi.org/10.1093/ntr/ntaa075
[12] Chinese Center for Disease Control and Prevention. Global Adult Tobacco Survey (GATS): Comparison fact sheet—China 2010 & 2018. https://www.who.int/docs/default-source/wpro---documents/countries/china/2018-gats-china-factsheet-cn-en.pdf. [2020-05-21].https://www.who.int/docs/default-source/wpro---documents/countries/china/2018-gats-china-factsheet-cn-en.pdf
[13] Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328:1519. http://dx.doi.org/10.1136/bmj.38142.554479.AECrossRef
[14] Zhou MG, Wang HD, Zeng XY, Yin P, Zhu J, Chen WQ, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019;394(10204):1145 − 58. http://dx.doi.org/10.1016/S0140-6736(19)30427-1CrossRef
[15] World Health Organization. Tobacco free initiative (TFI). https://www.who.int/tobacco/mpower/en/. [2020-05-21].https://www.who.int/tobacco/mpower/en/
[16] Fong GT, Hyland A, Borland R, Hammond D, Hastings G, McNeill A, et al. Reductions in tobacco smoke pollution and increases in support for smoke-free public places following the implementation of comprehensive smoke-free workplace legislation in the Republic of Ireland: Findings from the ITC Ireland/UK Survey. Tob Control 2006;15(SIII):iii51 − 8. http://dx.doi.org/10.1136/tc.2005.013649CrossRef
[17] Elton-Marshall T, Xu SS, Meng G, Quah ACK, Sansone GC, Feng GZ, et al. The lower effectiveness of text-only health warnings in China compared to pictorial health warnings in Malaysia. Tob Control 2015;24(S4):iv6 − 13. http://dx.doi.org/10.1136/tobaccocontrol-2015-052616CrossRef
[18] Sansone G, Fong GT, Yan M, Meng G, Craig L, Xu SS, et al. Secondhand smoke exposure and support for smoke-free policies in cities and rural areas of China from 2009 to 2015: a population-based cohort study (the ITC China Survey). BMJ Open 2019;9(12):e031891. http://dx.doi.org/10.1136/bmjopen-2019-031891CrossRef
[19] ITC Project and Tobacco Control Office, China CDC. ITC China project report. Findings from the wave 1 to 5 surveys (2006-2015). Waterloo, Ontario, Canada: University of Waterloo, Beijing, China: Tobacco Control Office, Chinese Center for Disease Control and Prevention. https://itcproject.s3.amazonaws.com/uploads/documents/ITC_China_Project_Report_Waves_1_to_5_2006-2015_Octo.pdf. [2020-05-21].https://itcproject.s3.amazonaws.com/uploads/documents/ITC_China_Project_Report_Waves_1_to_5_2006-2015_Octo.pdf
[20] Gravely S, Giovino GA, Craig LV, Commar A, d'Espaignet ET, Schotte K, et al. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health 2017;2(4):e166 − 74. http://dx.doi.org/10.1016/S2468-2667(17)30045-2CrossRef